Neisseria meningitidis is the main cause of meningitis and sepsis, potentially life-threatening
conditions. Thanks to advancements in vaccine development, vaccines are now available …

Outer membrane vesicles (OMVs) are spontaneously released by many gram-negative
bacteria during their growth and constitute an important virulence factor for bacteria, helping …

This report compiles and summarizes all recommendations from CDC's Advisory Committee
on Immunization Practices (ACIP) for use of meningococcal vaccines in the United States …

Abstract Background In September 2015, the four-component, protein-based meningococcal
serogroup B vaccine (4CMenB; Bexsero) became available for private purchase in Spain …

Importance A 4-component meningococcus group B vaccine (4CMenB) is the only vaccine
in use to prevent group B invasive meningococcal disease in young children, but no …

The 4-component meningococcal serogroup B (MenB) vaccine, 4CMenB, the first broadly
protective, protein-based MenB vaccine to be licensed, is now registered in more than 50 …

This review summarizes the recent Global Meningococcal Initiative (GMI) regional meeting,
which explored meningococcal disease in North America. Invasive meningococcal disease …

As microbial genomics makes increasingly important contributions to clinical and public
health microbiology, the interpretation of whole-genome sequence data by nonspecialists …

Introduction Vaccines based on multiple antigens often induce an immune response, which
is higher than that triggered by each single component, with antibodies acting cooperatively …

Serogroup B meningococci (MenB) remain a prominent cause of invasive meningococcal
disease (IMD). The protein-based multicomponent 4CMenB and the bivalent MenB-FHbp …